{"schema_version":"secwatch.filing_event.v1","accession":"0000055529-24-000018","form_type":"8-K","ticker":"KEQU","cik":"0000055529","company_name":"KEWAUNEE SCIENTIFIC CORP /DE/","filed_at":"2024-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.661490+00:00","generated_at":"2026-06-01T01:59:27.702643+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.72,"calibrated_materiality_score":0.72,"confidence":"high","headline":"Kewaunee Q4 sales up 5%, adjusted EPS $1.55 vs $0.34; backlog rises to $155.6M","bullets":["Q4 sales $56.7M (+5% YoY); GAAP net earnings $11.0M (diluted EPS $3.71) include two non-recurring items.","Adjusted pre-tax earnings $5.37M (+131% YoY); adjusted diluted EPS $1.55 vs $0.34.","Adjusted EBITDA for Q4 $6.28M vs $3.31M prior year; order backlog $155.6M (up from $147.9M a year ago).","Domestic segment sales $35.9M (+2.1% YoY); segment net earnings $3.41M vs $2.40M.","Non-recurring transactions impacted GAAP results; management provides adjusted non-GAAP metrics for comparability."],"urls":{"canonical":"https://secwatch.observer/filing/0000055529-24-000018","json":"https://secwatch.observer/filing/0000055529-24-000018.json","markdown":"https://secwatch.observer/filing/0000055529-24-000018.md","text":"https://secwatch.observer/filing/0000055529-24-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/55529/000005552924000018/0000055529-24-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/55529/000005552924000018/kequ-20240626.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T01:59:27.702643+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}